Pancreatic stellate cells (PSCs) play a critical role in fibrogenesis during alcoholic chronic pancreatitis (ACP). Transforming growth factor-beta1 (TGF-b1) is a key regulator of extracellular matrix production and PSC activation. Endotoxin lipopolysaccharide (LPS) has been recognized as a trigger factor in the pathogenesis of ACP.
involved in the activation process, including cytokines, cell-surface receptors, signal transduction molecules and factors that regulate PSC gene expression at the transcriptional and post-transcriptional levels. [1] [2] [3] Transforming growth factor-beta 1 (TGF-b1) was found to regulate activation and proliferation of PSCs in an autocrine fashion via Smad2, Smad3 and ERK pathways. 4, 7, 8 Therefore, activation of
PSCs is a critical step in the development of pancreatic fibrosis.
Additionally, an important role for macrophages (Mφs) as regulators of inflammation and fibrosis in mice and human chronic pancreatitis has recently become apparent. 9 The fact that only 5%-10% of alcoholics eventually develop overt pancreatitis indicates that ethanol alone is insufficient to lead to clinical pancreatitis. 1, 4, 10 Over the last decade, bacterial endotoxin lipopolysaccharide (LPS) has been recognized as a trigger of fibrogenesis and PSC activation during ACP. 11 Toll-like receptor 4 (TLR4) is the primary receptor implicated in signal transduction events induced by LPS. 12 Recently, we demonstrated that LPS enhances the production of chemotactic cytokines and TGF-b1 in human Mφs and that LPS binds to TLR4 on rat PSC to activate downstream effector NFkB through adaptor protein MyD88 and regulate cytokine expression. 13, 14 However, the interplay between Mφs and PSCs as well as the molecular link between pancreatic inflammation and fibrogenesis in ACP remains unclear.
This study was designed to determine mechanisms of ACP by which LPS enhances TGF-b1 signalling and pancreatic fibrosis using an in vivo model of chronic alcohol (ALC) feeding challenged with repeated LPS injection and in vitro Mφ and PSC models.
2 | ME TH ODS
| In vivo model of chronic ALC exposure AE LPS injections
Twenty-two male Sprague-Dawley rats (120 AE 10 g) were fed with an ALC liquid diet (ALC; 15 g/kg/d; 36% of total calories) according to the general formulation of Lieber-DeCarli 15 for 10 weeks. The rats were randomly divided into 2 groups on the 6th day of week 8:
(1) ALC-fed rats in which LPS (3 mg/kg body weight) were administered weekly via the tail vein injection for 3 weeks; or (2) control ALC-fed rats that received a volume of saline identical to the volume of LPS solution. Eleven animals from each group were killed at the end of week 10. Each pancreas was retrieved and cut into 3 parts (proximal, middle and distal pancreas). Samples were further divided into smaller pieces and fixed in 10% neutral buffer formalin or snapfrozen in liquid nitrogen. The study was performed in accordance with the guiding principles for the care and use of laboratory animals approved by the Ethics Committee on Animal Experiments of the First Hospital of Jilin University. 
| Patient's cohorts

| Generation and culture of rat Mφs and PSCs
To prepare monocyte-derived Mφ, rat peripheral blood mononuclear cells (PBMCs) were isolated from buffy coat preparation using human lymphocyte separation medium (Dakewe, China), and then monocytes were further enriched by CD14 magnetic beads (Miltenyi Biotec). Monocytes were cultured in 6-well culture plates or 4-well Lab-Tek â chamber slides with complete RPMI medium containing 10 ng/mL human M-CSF. Rat Mφs were used from Day 6
onwards. 17 The immortalized rat PSC line, RP-2, was cultured in DMEM supplemented with 25 mmol/L Herpes buffer and 10% FBS as described. 14 
| Aniline blue collagen stain
Formalin-fixed, paraffin-embedded sections (5 lm) were dewaxed and rehydrated. The sections were stained with 0.7% ponceau red solution for 10 seconds, followed by sequential incubation in 0.2% glacial acetic acid and 1% phosphomolybdic acid hydrate solution.
The sections were then stained with aniline blue solution (2 g aniline blue in 1% glacial acetic acid. IgG (Beyotime) and washed extensively with TBS/T before detection using the ECL system (Thermo, USA).
| Enzyme-linked immunosorbent assay
The supernatants from homogenates of pancreatic samples or cultured Mφs and RP-2 cells were measured with ELISA kits for Col1A1, or TGF-b1 (Uscn Life Science Inc, TX, USA) according to the manufacturer's protocols. Briefly, microtitre wells were pre-coated with 100 lL of each standard or supernatants for 1 hour at 37°C.
The plates were then developed by sequential addition of biotinylated primary antibody, avidin-conjugated horseradish peroxidase and tetramethylbenzidine substrate solution, and the colour reaction was measured at 450 nm.
| Statistical analysis
GraphPad Prism (version 5.0, GraphPad Software Inc. San Diego, CA)
was used to run all statistical tests. Data were presented as mean AE SEM. P < .05 was considered to be statistically significant.
3 | RESULTS
| LPS enhances pancreatic fibrosis and PSC activation in ALC-exposed rats
As pancreatic fibrosis is a key pathological feature of ACP in which
PSCs play a critical role, we first measured collagen deposition and Col1A1 content in pancreatic tissue samples from ALC rats or ALC + LPS rats by aniline blue stain or ELISA, respectively. Repeated D) ; (E) The expression of TLR4 protein was examined by Western blot analysis (top panels) and the results, normalized with GAPDH, are the mean AE SEM of triplicate determinations (bottom panels). Student's t test, *P < .05, ***P < .001 vs ALC rats (n = 11/group) SUN ET AL.
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LPS injection increased collagen deposition in the pancreas of ALC rats ( Figure 1A ). The percentage of fibrotic (blue) regions and Col1A1 content were significantly higher in the pancreas of ALC + LPS rats than those of ALC rats ( Figure 1C and D) (both P < .001). As expected, a few activated PSCs were found in ALC rats but many in ALC + LPS rats ( Figure 1B ). The number of activated PSCs was significantly increased in ALC + LPS rats vs ALC rats ( Figure 1E ) (P < .001).
| LPS induces overexpression of pancreatic TLR4 in ALC-exposed rats
To confirm whether TLR4 pathway was associated with the activa- and D) (both P < .001). Similarly, TLR4 protein in pancreatic tissues was also statistically increased in ACL + LPS rats vs ALC rats as assessed by Western blot analysis ( Figure 2E ) (P < .05).
| LPS induces low expression of BAMBI in PSCs
of ALC-exposed rats were female, with mean age of 29.9 AE 5.66 years. Of 29 ACP cases, 62% of cases had endotoxemia. The serum LPS values were significantly higher in ACP with endotoxemia than those in healthy controls (P < .001) ( Figure 4G ). The serum TGF-b1 levels in ACP patients with/without endotoxemia were higher than those in healthy controls (both P < .001), with the highest level in ACP with endotoxemia (P < .001) ( Figure 4H ). There was a positive correlation F I G U R E 4 TGF-b1 production was enhanced by LPS in the pancreas of ALC-fed rats and in the sera of ACP patients. (A, B) Doubleimmunofluorescence labelling using antibodies for TGF-b1 and F4/80 or a-SMA. Yellow, colocalization of two antibodies. Scale bar = 50 lm; (A) Yellow staining indicates TGF-b1-positive Mφs; (B) Yellow staining indicates TGF-b1-positive PSCs. The number of TGF-b1-positive Mφs/ PSCs was higher in the pancreas of ALC + LPS rats than that of ALC rats (C, D); (E) The expression of TGF-b1 protein was determined by ELISA. Student t test, **P < .01, ***P < .001 vs ALC rats. (F) There was a positive correlation between TGF-b1 and Col1A1 in the pancreas of LPS-treated ALC rats. Pearson's correlation test, r = .541, P < .01 (n = 11/group). (G) The LPS levels in the sera of ACP patients and healthy control (Ctrl); (H) The TGF-b1 levels in the sera of ACP patients with/without endotoxemia and Ctrl group. One-way ANOVA followed by Bonferroni post hoc test, ***P < .001 vs Ctrl, ### P < .001 vs ACP without endotoxemia. (I) There was a positive correlation between TGF-b1
and LPS in the sera of ACP patients with endotoxemia. Pearson's correlation test, r = .609, P < .01. (Ctrl: n = 25; ACP without endotoxemia: n = 11; ACP with endotoxemia: n = 18)
between serum LPS and TGF-b1 levels in ACP with endotoxemia (r = .607, P < .01) ( Figure 4I ).
| LPS up-regulates TLR4 and induces TGF-b1 production in cultured Mφs and PSCs
We next measured the production of TLR4 and TGF-b1 in cultured Mφs and RP-2 cells by immunocytochemistry or ELISA.
The expression of TLR4 was enhanced in Mφs and RP-2 cells under LPS stimulation ( Figure 5A and B). Mφ and PSC are major producers of TGF-b1 and active form of TGF-b1 secreted by both cells only constitutes a small proportion of total TGF-b1 (latent and active forms). The latent TGF-b1 as a high molecular weight must be processed to a lower molecular weight, biologically active form which can be detected by commercial ELSA kit. 18, 19 ELISA detection showed that the secretion of TGF-b1 in cultured Mφs and RP-2 cells was significantly increased under LPS stimulation compared to no addition ( Figure 5C and D) (both P < .001).
| LPS enhances TGF-b1-induced PSC activation and Col1 synthesis through down-regulation of BAMBI
Having shown an effect of LPS on TGF-b1 production after ALC exposure in vivo or in cultured Mφs and RP-2, we next investigated the role of LPS or TGF-b1 on PSC action. Col1A1 and a-SMA mRNA expression levels were significantly increased in cultured RP-2 cells under individual or combined treatment with LPS or TGF-b1 as compared to non-treated cells (P < .05, P < .001, P < .001, respectively), with the highest level of stimulation resulting from their combined effects (both P < .001) ( Figure 6A and B).
Similarly, Col1 and a-SMA protein contents were also increased in cultured RP-2 cells that were pre-treated with LPS or TGF-b1 or LPS + TGF-b1 ( Figure 6C ).
To gain further insight into the mechanism of LPS on TGF-b1 action, we next studied the production of TLR4 or BAMBI. TLR4 
| LPS down-regulates BAMBI through MyD88-NF-kB-dependent pathway
| DISCUSSION
Although excessive ALC consumption is commonly associated with pancreatitis, ethanol alone does not appear to be sufficient to initiate
LPS sensitizes PSCs to TGF-b1 and down-regulates BAMBI. Col1A1 and a-SMA mRNA levels (A, B) or Col1 and a-SMA protein contents (C) in the RP-2 cells after 12 h and 24 h of stimulation with LPS (100 ng/mL) or TGF-b1 (10 ng/mL) or in combination were determined by qPCR or Western blot, respectively. One-way ANOVA followed by Bonferroni post hoc test, *P < .05, ***P < .001 vs N/A; ### P < .001 vs LPS or TGF-b1 group. TLR4 mRNA levels (D) or protein contents (E) were determined in the RP-2 cells that had been incubated for 12 h or 24 h in the absence or presence of LPS (100 ng/mL); BAMBI mRNA levels F or protein contents (G) were determined in the RP-2 cells after 12 h or 24 h of stimulation with LPS (100 ng/mL); Before treatment, RP-2 cells were pre-transfected with either small interfere control RNA (Si-Ctrl) or small interfere TLR4 RNA (Si-TLR4) for 24 h; Col1A1 and a-SMA mRNA levels (H, I) or ERK1/2 and p38 and Smad2/3 phosphorylations (J) were determined in the RP-2 cells after 12 h or 24 h of stimulation with TGF-b1 (10 ng/mL); Before treatment, RP-2 cells were pre-transfected with either Si-Ctrl or small interfere BAMBI RNA (Si-BAMBI) for 24 h. Student's t test, **P < .01, ***P < .001 vs Si-Ctrl group (n = 6/group) clinical pancreatitis. 1, 4 This notion is further supported by the fact that administration of ethanol alone to experimental animals does not cause pancreatitis. 11, 20 Currently, it is widely believed that ethanol sensitizes the pancreas to injury and that additional factors are required for the manifestation of overt pancreatitis. 1, 10, 21 Bacterial endotoxin LPS has been recognized as a trigger factor, as shown by our clinical data that enhanced chemotactic factors and TGF-b1 are found in the sera of ACP patients with endotoxemia as well as by other experimental evidence that an LPS challenge in ALC-fed rats leads to pancreatitis. 10, 11 As chronic ALC consumption is known to increase gut permeability and decrease the phagocytic capacity of Kupffer cells, it is possible that an inability to detoxify circulating endotoxin may make some drinkers susceptible to overt disease. 22, 23 These observations underscore the difficulty of establishing animal models of ACP by ALC feeding alone. Recently, our study showed that male Sprague-Dawley rats challenged with repeated LPS injections (3 mg/kg body weight once a week for 3 weeks) revealed up-regulation of TLR4 and increase of cytokines/chemokines (TNF-a, IL-1, IL-6, MIP-1 and Rantes) as compared to control rats but no significant difference in pancreatic fibrosis between two groups (data not shown). Other studies have suggested that inclusion of a "second-hit" in ALC feeding animal models is more clinically relevant. 11, 24 In support of this, and consistent with a previous report, 11 HSCs and fibroblasts. 25, 26 In previous in vitro studies, we have shown that LPS up-regulates TLR4 and CD14 in human Mφs and rat PSCs, both of which produce chemotactic cytokines (MCP-1, MIP-1a
and Rantes), which are believed to induce PSC activation and Mφ chemostasis. 4, 13, 14, 27 We have also demonstrated that gut-derived endotoxin has the capacity to up-regulate TLR4, chemotactic cytoki- pancreatic fibrosis by activating PSCs. 29 Recently, our studies indicate that TGF-b1 promotes PSC functions, including cell migration, production of Col1, MMP-1 and MMP-2, and inhibition of TIMP-2.
14 Upon TGF-b1 stimulation, the TGF-b type II receptor (TbRII) kinase phosphorylates TbRI whereupon Smad2 and Smad3 (R-Smad) become phosphorylated and form heterodimers with Smad4 (CoSmad); the complexes then translocate into the nucleus, bind to DNA, and activate the transcription of target genes. 7 Studies have revealed that TGF-b1 stimulates PSC activation in a Smad2-dependent fashion, while TGF-b1/Smad3 transduction pathway transmits signals to promote collagen synthesis and PSC activation. 7, 30 IL-1b-induced TGF-b1 production and TGF-b1 autoinduction in PSCs were regulated through ERK1/2-dependent pathway. BAMBI is a TGF-b family type I receptor that lacks an intracellular kinase domain and which blocks signal transduction after stimulation with ligands such as TGF-bs, BMP and activin. 33, 34 Expression of BAMBI inhibits TGF-b signalling and promotes tumour growth and metastasis in human gastric cancer. 35 In contrast, down-regulation of BAMBI in non-small cell lung cancer enhances TGF-b signalling and tumour invasion. 36 BAMBI knockdown reduces the anti-adipogenic effects of TGF-b1 and Wnt3a. 37 BAMBI inhibits skin fibrosis by suppressing TGF-b1-induced fibroblast cell proliferation and excessive accumulation Col1.
38
BAMBI down-regulation sensitizes HSCs to TGF-b1 and facilitates hepatic fibrosis. 39 Whereas, overexpression of BAMBI in the lung of idiopathic pulmonary fibrosis patients and in TGF-b1-treated small airway epithelial cells may play a role in the process of pulmonary fibrosis. 40 In this study, we demonstrated that LPS enhanced TGF-b1-induced activation and Col1 synthesis in quiescent (serum-starved) RP-2 cells by suppressing BAMBI. Additionally, knockdown BAMBI with Si-BAMBI RNA significantly increased TGF-b1-induced PSC function and signalling pathway. As BAMBI suppression by LPS was followed by up-regulation of TLR4 and MyD88 and phosphorylation of NF-kB p50/p65, all of which were antagonized by Si-TLR4 RNA or by inhibitors of MyD88/NF-kB, we propose that upon LPS recognition, TLR4
undergoes oligomerization and recruits its downstream adaptors through MyD88-dependent pathway to activate IkBa. These events in turn activate NF-kB and regulate the expression of BAMBI in RP-2 cells. Further studies for silencing p50 or p65 will help to clarify the relationship between BAMBI and NF-kB dimerization, their precise location in PSCs.
In conclusion, in an ALC-fed rat model that involves LPS challenge, TGF-b1 is produced via paracrine and autocrine pathways in, respectively, Mφ and PSC, leading to PSC activation and Col1 synthesis. In in vitro studies, we show that LPS synergizes with TGF-b1
to facilitate activation and collagen synthesis in PSC via mechanisms that involve repression of BAMBI via TLR4/MyD88/NF-kB signalling.
Our results show that targeting of bacterial endotoxins, or their downstream mediators, may be a promising therapeutic strategy for ACP.
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